论文信息 - Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. - 字舞流文

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.

A. Panigrahy | I. Pollack | S. Partap | G. Robinson | M. Fouladi | D. Parsons | A. Adesina | S. Goldman | A. Onar-Thomas | T. Poussaint | I. Dunkel | C. Billups | A. Broniscer | R. Jakacki | N. Robison | L. Kilburn